Follow
Arnas Rakauskas
Arnas Rakauskas
Imperial College London
Verified email at nhs.net - Homepage
Title
Cited by
Cited by
Year
A novel nomogram to identify candidates for extended pelvic lymph node dissection among patients with clinically localized prostate cancer diagnosed with magnetic resonance …
G Gandaglia, G Ploussard, M Valerio, A Mattei, C Fiori, N Fossati, ...
European urology 75 (3), 506-514, 2019
2422019
The key combined value of multiparametric magnetic resonance imaging, and magnetic resonance imaging–targeted and concomitant systematic biopsies for the prediction of adverse …
G Gandaglia, G Ploussard, M Valerio, A Mattei, C Fiori, M Roumiguié, ...
European urology 77 (6), 733-741, 2020
972020
Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer: a multi-institute 15-year experience
D Reddy, M Peters, TT Shah, M van Son, MB Tanaka, PM Huber, ...
European Urology 81 (4), 407-413, 2022
542022
Prognostic implications of multiparametric magnetic resonance imaging and concomitant systematic biopsy in predicting biochemical recurrence after radical prostatectomy in …
G Gandaglia, G Ploussard, M Valerio, G Marra, M Moschini, A Martini, ...
European urology oncology 3 (6), 739-747, 2020
342020
Focal therapy for prostate cancer: complications and their treatment
A Rakauskas, G Marra, I Heidegger, V Kasivisvanathan, A Kretschmer, ...
Frontiers in Surgery 8, 696242, 2021
182021
Identification of urine biomarkers to improve eligibility for prostate biopsy and detect high-grade prostate cancer
N Alijaj, B Pavlovic, P Martel, A Rakauskas, V Cesson, K Saba, ...
Cancers 14 (5), 1135, 2022
72022
The impact of local staging of prostate cancer determined on MRI or DRE at time of radical prostatectomy on progression-free survival: A Will Rogers phenomenon
A Rakauskas, M Peters, D Ball, NH Kim, HU Ahmed, M Winkler, TT Shah
Urologic Oncology: Seminars and Original Investigations 41 (2), 106. e9-106. e16, 2023
52023
Can quantitative analysis of multi-parametric MRI independently predict failure of focal salvage HIFU therapy in men with radio-recurrent prostate cancer?
A Rakauskas, TT Shah, M Peters, JS Randeva, F Hosking-Jervis, ...
Urologic Oncology: Seminars and Original Investigations 39 (12), 830. e1-830. e8, 2021
52021
Unilateral pelvic lymph node dissection in prostate cancer patients diagnosed in the era of magnetic resonance imaging–targeted biopsy: a study that challenges the dogma
A Martini, L Wever, TFW Soeterik, A Rakauskas, CD Fankhauser, ...
The Journal of Urology 210 (1), 117-127, 2023
42023
Do cancer detection rates differ between transperineal and transrectal micro-ultrasound mpMRI-fusion-targeted prostate biopsies? A propensity score-matched study
A Rakauskas, M Peters, P Martel, PSN van Rossum, S La Rosa, ...
PloS one 18 (1), e0280262, 2023
32023
Active surveillance in males with low-to intermediate-risk localized prostate cancer: A modern prospective cohort study
A Rakauskas, T Tawadros, I Lucca, F Herrera, J Bourhis, R Burruni, ...
Investigative and Clinical Urology 62 (4), 416, 2021
32021
Toxicity, quality of life, and PSA control after 50 Gy stereotactic body radiation therapy to the dominant intraprostatic nodule with the use of a rectal spacer: results of a …
M Cloitre, M Valerio, A Mampuya, A Rakauskas, D Berthold, T Tawadros, ...
The British Journal of Radiology 96 (1145), 20220803, 2023
22023
WITHDRAWN: The benefit of adopting Microultrasound in the prostate cancer imaging pathway: A lesion-by-lesion analysis
P Martel, A Rakauskas, J Dagher, S La Rosa, JY Meuwly, B Roth, ...
Progrès en Urologie, 2022
2*2022
Unilateral pelvic lymph node dissection in prostate cancer patients diagnosed in the era of MRI-targeted biopsy: a study that challenges the dogma
A Martini, L Wever, TFW Soeterik, A Rakauskas, CD Fankhauser, ...
European Urology Open Science 45, S103-S104, 2022
12022
PD57-02 WHEN IS MP-MRI RELIABLE IN PREDICTING EXTRA-PROSTATIC EXTENSION IN PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY? RESULTS FROM A LARGE, MULTI …
G Gandaglia*, G Ploussard, M Valerio, A Mattei, G Marra, JB Beauval, ...
The Journal of Urology 203 (Supplement 4), e1193-e1194, 2020
12020
The utility of high-frequency micro-ultrasound in performing MRI-ultrasound fusion targeted biopsy
P Martel, T Tawadros, R Burruni, A Rakauskas, JY Meuwly, S La Rosa, ...
European Urology Supplements 18 (10), e3392, 2019
12019
MP19-15 THE SIGNIFICANT ADDED VALUE OF CONCOMITANT SYSTEMATIC PROSTATE BIOPSIES IN ADDITION TO TARGETED SAMPLING IN PATIENTS WITH PREVIOUS NEGATIVE BIOPSIES. IMPLICATIONS FOR …
D Robesti, F Pellegrino, A Stabile, F Barletta, S Scuderi, G Ploussard, ...
The Journal of Urology 211 (5S), e316, 2024
2024
PD45-05 WHEN DOES SYSTEMATIC BIOPSY INFORMATION MATTER THE MOST? IDENTIFYING INDEPENDENT PREDICTORS OF DISEASE DOWNGRADING AT RADICAL PROSTATECTOMY IN HIGH GRADE PROSTATE …
G Sorce, A Stabile, M Longoni, P Scilipoti, G Ploussard, G Marra, ...
The Journal of Urology 211 (5S), e969, 2024
2024
The impact of mpMRI-targeted vs systematic biopsy on the risk of prostate cancer downgrading at final pathology
G Sorce, A Stabile, F Pellegrino, E Mazzone, A Mattei, L Afferi, S Serni, ...
World Journal of Urology 42 (1), 248, 2024
2024
The significant added value of concomitant systematic prostate biopsies in addition to targeted sampling in patients with previous negative biopsies. Implications for accurate …
D Robesti, F Pellegrino, A Stabile, F Barletta, S Scuderi, G Ploussard, ...
European Urology 85, S746-S747, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20